Recent progress concerning CpG DNA and its use as a vaccine adjuvant

被引：155
作者：
Shirota, Hidekazu [1 ]
Klinman, Dennis M. [2 ]
机构：
[1] Tohoku Univ, Dept Clin Oncol, Sendai, Miyagi 980, Japan
[2] NCI, Canc & Inflammat Program, Frederick, MD 21702 USA
来源：
EXPERT REVIEW OF VACCINES | 2014年 / 13卷 / 02期
基金：
美国国家卫生研究院;
关键词：
allergy; cancer; CpG oligonucleotide; infection; Toll-like receptor; vaccine adjuvant; PLASMACYTOID DENDRITIC CELLS; B SURFACE-ANTIGEN; TOLL-LIKE RECEPTORS; DOUBLE-STRANDED-RNA; MUCOSAL IMMUNE-RESPONSES; NON-HODGKIN-LYMPHOMA; IN-SITU VACCINATION; BLOOD-STAGE VACCINE; RANDOMIZED PHASE-II; BACTERIAL-DNA;
D O I：
10.1586/14760584.2014.863715
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
CpG Oligonucleotides (ODN) are immunomodulatory synthetic oligonucleotides designed to specifically agonize Toll-like receptor 9. Here, we review recent progress in understanding the mechanism of action of CpG ODN and provide an overview of human clinical trial results using CpG ODN to improve the vaccines for cancer, allergy and infectious disease.
引用
收藏
页码：299 / 312
页数：14
相关论文
共 163 条
[31]   Alginate-coated chitosan nanogel capacity to modulate the effect of TLR ligands on blood dendritic cells [J].
Demoulins, Thomas ;
Bassi, Isabelle ;
Thomann-Harwood, Lisa ;
Jandus, Camilla ;
Kaeuper, Peter ;
Simon, Hans-Uwe ;
von Gunten, Stephan ;
McCullough, Kenneth C. .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2013, 9 (06) :806-817
[32]   Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres [J].
Diwan, M ;
Tafaghodi, M ;
Samuel, J .
JOURNAL OF CONTROLLED RELEASE, 2002, 85 (1-3) :247-262
[33]   Impact on Malaria Parasite Multiplication Rates in Infected Volunteers of the Protein-in-Adjuvant Vaccine AMA1-C1/Alhydrogel+CPG 7909 [J].
Duncan, Christopher J. A. ;
Sheehy, Susanne H. ;
Ewer, Katie J. ;
Douglas, Alexander D. ;
Collins, Katharine A. ;
Halstead, Fenella D. ;
Elias, Sean C. ;
Lillie, Patrick J. ;
Rausch, Kelly ;
Aebig, Joan ;
Miura, Kazutoyo ;
Edwards, Nick J. ;
Poulton, Ian D. ;
Hunt-Cooke, Angela ;
Porter, David W. ;
Thompson, Fiona M. ;
Rowland, Ros ;
Draper, Simon J. ;
Gilbert, Sarah C. ;
Fay, Michael P. ;
Long, Carole A. ;
Zhu, Daming ;
Wu, Yimin ;
Martin, Laura B. ;
Anderson, Charles F. ;
Lawrie, Alison M. ;
Hill, Adrian V. S. ;
Ellis, Ruth D. .
PLOS ONE, 2011, 6 (07)
[34]   BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation [J].
Eckl-Dorna, Julia ;
Batista, Facundo D. .
BLOOD, 2009, 113 (17) :3969-3977
[35]  
Elkins KL, 1999, J IMMUNOL, V162, P2291
[36]   Phase 1 Trial of the Plasmodium falciparum Blood Stage Vaccine MSP142-C1/Alhydrogel with and without CPG 7909 in Malaria Naive Adults [J].
Ellis, Ruth D. ;
Martin, Laura B. ;
Shaffer, Donna ;
Long, Carole A. ;
Miura, Kazutoyo ;
Fay, Michael P. ;
Narum, David L. ;
Zhu, Daming ;
Mullen, Gregory E. D. ;
Mahanty, Siddhartha ;
Miller, Louis H. ;
Durbin, Anna P. .
PLOS ONE, 2010, 5 (01)
[37]   A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel® with CPG 7909, using two different formulations and dosing intervals [J].
Ellis, Ruth D. ;
Mullen, Gregory E. D. ;
Pierce, Mark ;
Martin, Laura B. ;
Miura, Kazutoyo ;
Fay, Michael P. ;
Long, Carole A. ;
Shaffer, Donna ;
Saul, Allan ;
Miller, Louis H. ;
Durbin, Anna P. .
VACCINE, 2009, 27 (31) :4104-4109
[38]   The potential of 1018 ISS adjuvant in hepatitis B vaccines HEPLISAV™ review [J].
Eng, Nelson F. ;
Bhardwaj, Nitin ;
Mulligan, Rebecca ;
Diaz-Mitoma, Francisco .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (08) :1661-1672
[39]  
Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405
[40]   Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase [J].
Ewald, Sarah E. ;
Engel, Alex ;
Lee, Jiyoun ;
Wang, Miqi ;
Bogyo, Matthew ;
Barton, Gregory M. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (04) :643-651
12345678910